Filed: 2/12/2025ACC: 0001104659-25-012093
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 89 equity positions with a total reported market value of $276.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
89
Positions
$276.52M
Total AUM (reported)
14.84M
Total Shares
Allocation by class
COMMON$276.52M100.0%
Portfolio Concentration
Top 3$147.50M53.3%
4–10$66.75M24.1%
11–25$41.62M15.1%
Rest$20.65M7.5%
Top 3 weight
53.3%
Top 10 weight
77.5%
Voting Authority Distribution
Total shares with voting rights: 14.84M
Sole
Full voting authority
14.84M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other89
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings89
Rows:
Calumet, Inc.
DFNDShares3.65M
TypeSH
Market value$80.40M
29.08%
Sole
3.65M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$37.16M
13.44%
Sole
225K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares590.40K
TypeSH
Market value$29.94M
10.83%
Sole
590.40K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$21.37M
7.73%
Sole
112.22K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares3.07M
TypeSH
Market value$13.02M
4.71%
Sole
3.07M
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares157.93K
TypeSH
Market value$8.01M
2.90%
Sole
157.93K
Shared
0.00
None
0.00
Verona Pharma PLC.
DFNDShares159.30K
TypeSH
Market value$7.40M
2.68%
Sole
159.30K
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares254.54K
TypeSH
Market value$6.75M
2.44%
Sole
254.54K
Shared
0.00
None
0.00
The Invesco AAA Floating Rate Note ETF
DFNDShares201.49K
TypeSH
Market value$5.17M
1.87%
Sole
201.49K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$5.03M
1.82%
Sole
20.98K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares210K
TypeSH
Market value$4.38M
1.58%
Sole
210K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares228K
TypeSH
Market value$3.97M
1.44%
Sole
228K
Shared
0.00
None
0.00
OmniAb Inc.
DFNDShares1.09M
TypeSH
Market value$3.87M
1.40%
Sole
1.09M
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares346.90K
TypeSH
Market value$3.65M
1.32%
Sole
346.90K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares1M
TypeSH
Market value$3.39M
1.23%
Sole
1M
Shared
0.00
None
0.00
BioCryst Pharmaceuticals, Inc.
DFNDShares440K
TypeSH
Market value$3.31M
1.20%
Sole
440K
Shared
0.00
None
0.00
Ardelyx, Inc.
DFNDShares612.27K
TypeSH
Market value$3.10M
1.12%
Sole
612.27K
Shared
0.00
None
0.00
Enstar Group Limited
DFNDShares7.50K
TypeSH
Market value$2.42M
0.87%
Sole
7.50K
Shared
0.00
None
0.00
Immunovant Inc.
DFNDShares92K
TypeSH
Market value$2.28M
0.82%
Sole
92K
Shared
0.00
None
0.00
CSX Corporation
DFNDShares70K
TypeSH
Market value$2.26M
0.82%
Sole
70K
Shared
0.00
None
0.00
Protagonist Therapeutics, Inc
DFNDShares52.37K
TypeSH
Market value$2.02M
0.73%
Sole
52.37K
Shared
0.00
None
0.00
Inozyme Pharma, Inc.
DFNDShares695K
TypeSH
Market value$1.93M
0.70%
Sole
695K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$1.78M
0.64%
Sole
48K
Shared
0.00
None
0.00
Syndax Pharmaceutical, Inc.
DFNDShares128K
TypeSH
Market value$1.69M
0.61%
Sole
128K
Shared
0.00
None
0.00
Viking Therapeutics, Inc.
DFNDShares39.04K
TypeSH
Market value$1.57M
0.57%
Sole
39.04K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet, Inc.DFND | Common | 3.65M | SH | $80.40M 29.08% | 3.65M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $37.16M 13.44% | 225K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 590.40K | SH | $29.94M 10.83% | 590.40K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $21.37M 7.73% | 112.22K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 3.07M | SH | $13.02M 4.71% | 3.07M | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 157.93K | SH | $8.01M 2.90% | 157.93K | 0.00 | 0.00 |
Verona Pharma PLC.DFND | Common | 159.30K | SH | $7.40M 2.68% | 159.30K | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 254.54K | SH | $6.75M 2.44% | 254.54K | 0.00 | 0.00 |
The Invesco AAA Floating Rate Note ETFDFND | Common | 201.49K | SH | $5.17M 1.87% | 201.49K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $5.03M 1.82% | 20.98K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 210K | SH | $4.38M 1.58% | 210K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 228K | SH | $3.97M 1.44% | 228K | 0.00 | 0.00 |
OmniAb Inc.DFND | Common | 1.09M | SH | $3.87M 1.40% | 1.09M | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 346.90K | SH | $3.65M 1.32% | 346.90K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 1M | SH | $3.39M 1.23% | 1M | 0.00 | 0.00 |
BioCryst Pharmaceuticals, Inc.DFND | Common | 440K | SH | $3.31M 1.20% | 440K | 0.00 | 0.00 |
Ardelyx, Inc.DFND | Common | 612.27K | SH | $3.10M 1.12% | 612.27K | 0.00 | 0.00 |
Enstar Group LimitedDFND | Common | 7.50K | SH | $2.42M 0.87% | 7.50K | 0.00 | 0.00 |
Immunovant Inc.DFND | Common | 92K | SH | $2.28M 0.82% | 92K | 0.00 | 0.00 |
CSX CorporationDFND | Common | 70K | SH | $2.26M 0.82% | 70K | 0.00 | 0.00 |
Protagonist Therapeutics, IncDFND | Common | 52.37K | SH | $2.02M 0.73% | 52.37K | 0.00 | 0.00 |
Inozyme Pharma, Inc.DFND | Common | 695K | SH | $1.93M 0.70% | 695K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $1.78M 0.64% | 48K | 0.00 | 0.00 |
Syndax Pharmaceutical, Inc.DFND | Common | 128K | SH | $1.69M 0.61% | 128K | 0.00 | 0.00 |
Viking Therapeutics, Inc.DFND | Common | 39.04K | SH | $1.57M 0.57% | 39.04K | 0.00 | 0.00 |
Page 1 of 4